GSK (GSK) Operating Margin (2006 - 2026)
GSK (GSK) operating margin from Mar 31, 2006 to Mar 31, 2026. The current GSK (GSK) operating margin is 30.06%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of GSK (GSK)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 25.52% | +99.17% |
| 2024 | 12.82% | -42.38% |
| 2023 | 22.24% | +1.38% |
| 2022 | 21.94% | +24.35% |
| 2021 | 17.64% | -28.14% |
| 2020 | 24.55% | +19.05% |
| 2019 | 20.62% | +15.92% |
| 2018 | 17.79% | +31.39% |
| 2017 | 13.54% | +45.34% |
| 2016 | 9.32% | -78.41% |
| 2015 | 43.15% | +175.96% |
| 2014 | 15.64% | -41.03% |
| 2013 | 26.52% | -3.99% |
| 2012 | 27.62% | -3.11% |
| 2011 | 28.51% | +113.94% |
| 2010 | 13.32% | -55.14% |
| 2009 | 29.70% | +1.28% |
| 2008 | 29.32% | -16.01% |
| 2007 | 34.91% | +12.80% |
| 2006 | 30.95% | N/A |
Comparison GSK (GSK) operating margin with competitors
GSK (GSK) operating margin is 30.06%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | +104.85% |
| GILD | Gilead Sciences Inc | 37.16% | +23.63% |
| NVS | Novartis AG | 31.31% | +4.17% |
| AMGN | AMGEN Inc | 30.94% | +2.94% |
| AZN | Astrazeneca plc | 27.77% | -7.61% |
| ABBV | Abbvie Inc | 26.60% | -11.50% |
| JNJ | Johnson & Johnson | 26.58% | -11.57% |
| SNY | Sanofi | 20.18% | -32.86% |
| OGN | Organon & Company | 18.22% | -39.38% |
| GRFS | Grifols SA | 14.65% | -51.26% |